THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation
Trial ID or NCT#
NCT01385202
Status
NOT RECRUITING
Purpose
The purpose of this study is to demonstrate the safety and effectiveness of the THERMOCOOL® SMARTTOUCH™ Catheters with Contact Force Sensing Capability in the treatment of drug refractory symptomatic paroxysmal Atrial Fibrillation (AF) during standard electrophysiology mapping and RF procedures.
Official Title
THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
- - Have had at least 3 atrial fibrillation episodes within 6 months of this study - Have failed at least one antiarrhythmic drug shown by repeated atrial fibrillation episodes - 18 years of age or older
Exclusion Criteria:
- - Have had previous ablation for atrial fibrillation - Have take amiodarone within 6 months of this study - Have had any heart surgery within the last 60 days - Have had a heart attack within the last 60 days - Females who are pregnant or breast feeding
Contact us to find out if this trial is right for you.
Contact
Linda Norton, RN, MSN
(650)725-5597
View on ClinicalTrials.gov
